financetom
Business
financetom
/
Business
/
Rubrik Fiscal Q1 Non-GAAP Loss Narrows, Revenue Rises; Shares Gain After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rubrik Fiscal Q1 Non-GAAP Loss Narrows, Revenue Rises; Shares Gain After Hours
Jun 5, 2025 1:42 PM

04:21 PM EDT, 06/05/2025 (MT Newswires) -- Rubrik ( RBRK ) reported fiscal Q1 non-GAAP loss late Thursday of $0.15 per diluted share, narrowing from the loss of $1.58 a year earlier.

Analysts polled by FactSet expected a loss of $0.32.

Revenue in the three months ended April 30 rose to $278.5 million from $187.3 million a year earlier.

Analysts surveyed by FactSet expected $260.4 million.

The company expects a Q2 adjusted loss of $0.33 to $0.35 a share on revenue of $281 million to $283 million. Analysts expect a loss of $0.36 on revenue of $273.3 million.

The company expects a fiscal 2026 adjusted loss of $0.96 to $1.02 a share on revenue of $1.38 billion to $1.39 billion. That compares with the March 13 forecast for a loss of $1.13 to $1.23 a share on revenue of $1.15 billion to $1.16 billion.

Analysts expect a loss of $1.17 on revenue of $1.16 billion.

The company's shares rose 3.4% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gossamer Bio Reports Phase 3 Trial of Seralutinib Missed Primary Endpoint
Gossamer Bio Reports Phase 3 Trial of Seralutinib Missed Primary Endpoint
Mar 11, 2026
08:58 AM EST, 02/23/2026 (MT Newswires) -- Gossamer Bio ( GOSS ) said Monday topline results from the phase 3 Prosera study showed seralutinib improved six-minute walk distance in pulmonary arterial hypertension patients, but failed to meet the prespecified statistical threshold for the primary endpoint. The trial's primary endpoint was placebo-adjusted change from baseline in six-minute walk distance at Week...
Fulton Financial, Blue Foundry Receive Regulatory Approvals for Merger
Fulton Financial, Blue Foundry Receive Regulatory Approvals for Merger
Mar 11, 2026
08:57 AM EST, 02/23/2026 (MT Newswires) -- Fulton Financial ( FULT ) and Blue Foundry Bancorp ( BLFY ) said Monday they received all required regulatory approvals for their previously announced all-stock merger. The companies said approvals were granted by the Federal Reserve Board and the Office of the Comptroller of the Currency, while Blue Foundry shareholders approved the transaction...
Kratos Defense & Security Solutions, GE Aerospace Win $12.4 Million Air Force Contract
Kratos Defense & Security Solutions, GE Aerospace Win $12.4 Million Air Force Contract
Mar 11, 2026
08:59 AM EST, 02/23/2026 (MT Newswires) -- Kratos Defense & Security Solutions (KTOS) and GE Aerospace (GE) said Monday that they have received a $12.4 million US Air Force contract to design a next-generation engine for small Collaborative Combat Aircraft. The companies said the initial phase will focus on completing the preliminary design of the GEK1500 engine, a 1,500-lb thrust...
Bausch Health Launches New Skin Laser in Canada
Bausch Health Launches New Skin Laser in Canada
Mar 11, 2026
08:58 AM EST, 02/23/2026 (MT Newswires) -- Bausch Health Companies ( BHC ) Monday announced the launch of Solta Medical's Clear + Brilliant Touch laser in Canada. The device, for dermatological use, was approved by Health Canada in May last year. The Solta business continues to expand its global presence through its diverse and well-established portfolio that supports the growing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved